- $158,000 ALS drug pulled from market after failing in large clinical trial | The drug is now unavailable to new patients; its maker to lay off 70% of employees. https://arstechnica.com/science/2024/04/158000-als-drug-pulled-from-market-after-failing-in-large-clinical-trial/ 21 comments health
Linking pages
- NASA knows what knocked Voyager 1 offline, but it will take a while to fix | Ars Technica https://arstechnica.com/space/2024/04/the-diagnosis-is-in-bad-memory-knocked-nasas-aging-voyager-1-offline/ 214 comments
- Apple now allows retro game emulators on its App Store—but with big caveats | Ars Technica https://arstechnica.com/gadgets/2024/04/apple-now-allows-retro-game-emulators-on-its-app-store-but-with-big-caveats/ 79 comments
Linked pages
- NASA knows what knocked Voyager 1 offline, but it will take a while to fix | Ars Technica https://arstechnica.com/space/2024/04/the-diagnosis-is-in-bad-memory-knocked-nasas-aging-voyager-1-offline/ 214 comments
- Apple now allows retro game emulators on its App Store—but with big caveats | Ars Technica https://arstechnica.com/gadgets/2024/04/apple-now-allows-retro-game-emulators-on-its-app-store-but-with-big-caveats/ 79 comments
- Biogen dumps dubious Alzheimer’s drug after profit-killing FDA scandal | Ars Technica https://arstechnica.com/science/2024/01/biogen-dumps-dubious-alzheimers-drug-after-profit-killing-fda-scandal/ 2 comments
Related searches:
Search whole site: site:arstechnica.com
Search title: $158,000 ALS drug pulled from market after failing in large clinical trial | Ars Technica
See how to search.